Health Canada drug identification number

DIN 02485680 — NOREPINEPHRINE BITARTRATE INJECTION USP 1 MG

NOREPINEPHRINE BITARTRATE INJECTION USP is a solution of Norepinephrine marketed by GENERIC MEDICAL PARTNERS INC. The full Norepinephrine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02485680
Brand name
NOREPINEPHRINE BITARTRATE INJECTION USP
Active ingredient
Norepinephrine
Strength
1 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
GENERIC MEDICAL PARTNERS INC
Health Canada status
DORMANT
Drug class
Sympathomimetic vasopressor (alpha- and beta-adrenergic agonist)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Norepinephrine products

DINBrandStrengthFormManufacturerStatus
02501430 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION 0.016 MG SOLUTION BAXTER CORPORATION MARKETED
02501449 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION 0.032 MG SOLUTION BAXTER CORPORATION MARKETED
02540630 NOREPINEPHRINE BITARTRATE INJECTION 1 MG SOLUTION JUNO PHARMACEUTICALS CORP. MARKETED
00893285 NOREPINEPHRINE BITARTRATE INJECTION USP 1 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02358743 NOREPINEPHRINE BITARTRATE INJECTION, USP 1 MG SOLUTION STERIMAX INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.